Peak6 LLC Uni Qure N.V. Call Options Transaction History

Peak6 LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2025 Nov 13, 2025	SELL	$13.28 - $59.4 $1.35 Million - $6.05 Million	-101,800 Reduced 90.17%	11,100 $647,000
Q2 2025 Aug 13, 2025	BUY	$8.34 - $17.27 $768,114 - $1.59 Million	92,100 Added 442.79%	112,900 $1.57 Million
Q1 2025 May 14, 2025	BUY	$10.6 - $18.08 $209,880 - $357,983	19,800 Added 1980.0%	20,800 $220,000
Q4 2024 Feb 13, 2025	BUY	$4.54 - $17.73 $4,540 - $17,730	1,000 New	1,000 $17,000

267

51.1M

3.92M

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $1.4B
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 LLC with notifications on news.